Early arthritis and rheumatoid arthritis in GermanyZEIDLER, H; MERKESDAL, S; HÜLSEMANN, J. L et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S106-S112, issn 0392-856X, SUP31Article

Early arthritisPINCUS, T; SMOLEN, J. S.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, issn 0392-856X, 211 p., SUP31Serial Issue

Early arthritis clinic: A USA perspectiveCUSH, J. J.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S75-S78, issn 0392-856X, SUP31Article

The Austrian Early Arthritis RegistryMACHOLD, K. P; NELL, V. P. K; STAMM, T. A et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S113-S117, issn 0392-856X, SUP31Article

The Leiden Early Arthritis ClinicVAN AKEN, J; VAN BILSEN, J. H. M; ALLAART, C. F et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S100-S105, issn 0392-856X, SUP31Article

The French early arthritis registryCOMBE, B.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S123-S128, issn 0392-856X, SUP31Article

Role of biologics in early arthritisEMERY, P; SETO, Y.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S191-S194, issn 0392-856X, SUP31Article

Autoantibodies in early arthritis: Advances in diagnosis and prognosticationHUEBER, W; UTZ, P. J; ROBINSON, W. H et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S59-S64, issn 0392-856X, SUP31Article

Work disability in early rheumatoid arthritisSOKKA, T.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S71-S74, issn 0392-856X, SUP31Article

Early rheumatoid arthritis in FinlandSOKKA, T.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S133-S137, issn 0392-856X, SUP31Article

The histopathology of early synovitisHITCHON, C. A; EL-GABALAWY, H. S.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S28-S36, issn 0392-856X, SUP31Article

The Norfolk Arthritis Register (NOAR)SYMMONS, D. P. M; SILMAN, A. J.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S94-S99, issn 0392-856X, SUP31Article

The Oslo experience with arthritis registriesKVIEN, T. K; UHLIG, T.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S118-S122, issn 0392-856X, SUP31Article

Combination therapy in early rheumatoid arthritisGOSSEC, L; DOUGADOS, M.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S174-S178, issn 0392-856X, SUP31Article

A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritisSOKKA, T; PINCUS, T.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S5-S14, issn 0392-856X, SUP31Article

Uniform databases in early arthritis: Specific measures to complement classification criteria and indices of clinical changePINCUS, T; SOKKA, T.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S79-S88, issn 0392-856X, SUP31Article

Low dose glucocorticoids in early rheumatoid arthritisSTRAND, V; SIMON, L. S.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S186-S190, issn 0392-856X, SUP31Article

The safety of biologic agents in early rheumatoid arthritisKAVANAUGH, A; KEYSTONE, E. C.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S203-S208, issn 0392-856X, SUP31Article

Databases of patients with early rheumatoid arthritis in the USASOKKA, T; WILLOUGHBY, J; YAZICI, Y et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S146-S153, issn 0392-856X, SUP31Article

Methotrexate as the anchor drug for the treatment of early rheumatoid arthritisPINCUS, T; YAZICI, Y; SOKKA, T et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S179-S185, issn 0392-856X, SUP31Article

Early predictors of outcome in juvenile idiopathic arthritisRAVELLI, A; MARTINI, A.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S89-S93, issn 0392-856X, SUP31Article

Role of adalimumab in the treatment of early rheumatoid arthritisKEYSTONE, E. C; HARAOUI, B; BYKERK, V. P et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S198-S199, issn 0392-856X, SUP31Article

Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritisSYMMONS, D. P. M; HAZES, J. M. W; SILMAN, A. J et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S2-S4, issn 0392-856X, SUP31Article

Diagnosing early rheumatoid arthritis (RA). What are the problems and opportunities ?SCHUMACHER, H. R; PESSLER, F; CHEN, L. X et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S15-S19, issn 0392-856X, SUP31Article

Biochemical markers of joint tissue turnover in early rheumatoid arthritisGARNERO, P; GEUSENS, P; LANDEWE, R et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 5, pp S54-S58, issn 0392-856X, SUP31Article